{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T21:09:42Z","timestamp":1774472982286,"version":"3.50.1"},"reference-count":58,"publisher":"University of Tokushima Faculty of Medicine","issue":"3.4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Invest."],"published-print":{"date-parts":[[2025]]},"DOI":"10.2152\/jmi.72.225","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:07:12Z","timestamp":1762207632000},"page":"225-234","source":"Crossref","is-referenced-by-count":1,"title":["Review of Multimodal Imaging in Cardiac Sarcoidosis"],"prefix":"10.2152","volume":"72","author":[{"given":"Leah Anne Christine L","family":"Bollos","sequence":"first","affiliation":[{"name":"Graduate School of Health Sciences, Tokushima University, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Kasai","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging\/Nuclear Medicine, Institute of Biomedical Sciences, Tokushima University, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichiro","family":"Takao","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, Institute of Biomedical Sciences, Tokushima University, Graduate School, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Kawabata","sequence":"additional","affiliation":[{"name":"Graduate School of Health Sciences, Tokushima University, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Otomi","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, Institute of Biomedical Sciences, Tokushima University, Graduate School, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Tanioka","sequence":"additional","affiliation":[{"name":"Department of Nursing Management, Institute of Biomedical Sciences, Tokushima University, Graduate School, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shusuke","family":"Yagi","sequence":"additional","affiliation":[{"name":"Department of Community and Family Medicine, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Ikushima","sequence":"additional","affiliation":[{"name":"Department of Therapeutic Radiology, Institute of Biomedical Sciences, Tokushima University, Graduate School, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Otsuka","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging\/Nuclear Medicine, Institute of Biomedical Sciences, Tokushima University, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"925","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Shah HH, Zehra SA, Shahrukh A, Waseem R, Hussain T, Hussain MS, Batool F, Jaffer M:Cardiac sarcoidosis:a comprehensive review of risk factors, pathogenesis, diagnosis, clinical manifestations, and treatment strategies. Front Cardiovasc Med 10:1156474, 2023. DOI:10.3389\/fcvm.2023.1156474.","DOI":"10.3389\/fcvm.2023.1156474"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Arkema EV, Cozier YC:Sarcoidosis epidemiology:recent estimates of incidence, prevalence and risk factors. Curr Opin Pulm Med 26:527-534, 2020. DOI:10.1097\/MCP.0000000000000715.","DOI":"10.1097\/MCP.0000000000000715"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Chareonthaitawee P, Gutberlet M:Clinical Utilization of Multimodality Imaging for Myocarditis and Cardiac Sarcoidosis. Circ Cardiovasc Imaging 16, 2023. DOI:10.1161\/CIRCIMAGING.122.014091.","DOI":"10.1161\/CIRCIMAGING.122.014091"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Lehtonen J, Uusitalo V, P\u00f6yh\u00f6nen P, M\u00e4yr\u00e4np\u00e4\u00e4 MI, Kupari M:Cardiac sarcoidosis:phenotypes, diagnosis, treatment, and prognosis. Eur Heart J 44:1495-1510, 2023. DOI:10.1093\/eurheartj\/ehad067.","DOI":"10.1093\/eurheartj\/ehad067"},{"key":"5","unstructured":"5. Hulten E, Aslam S, Osborne M, Abbasi S, Bittencourt MS, Blankstein R:Cardiac sarcoidosis-state of the art review. Cardiovasc Diagn Ther 6:50-63, 2016. PMID:26885492. DOI:10.3978\/j.issn.2223-3652.2015.12.13."},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Al-Kindi SG, Oliveira GH:Letter by Al-Kindi, Oliveira Regarding Article \u201cCardiac sarcoidosis:Epidemiology, characteristics, and outcome over 25 years in a nationwide study.\u201d Circulation 132, 2015. DOI:10.1161\/CIRCULATIONAHA.115.016258","DOI":"10.1161\/CIRCULATIONAHA.115.016258"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Blankstein R, Waller AH:evaluation of known or suspected cardiac sarcoidosis. Circ Cardiovasc Imaging 9:e000867, 2016. DOI:10.1161\/CIRCIMAGING.113.000867.","DOI":"10.1161\/CIRCIMAGING.113.000867"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Terasaki F, Ishizaka N:Deterioration of cardiac function during the progression of cardiac sarcoidosis:Diagnosis and treatment. Intern Med 53:1595-1605, 2014. DOI:10.2169\/internalmedicine.53.2784.","DOI":"10.2169\/internalmedicine.53.2784"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Cheng RK, Kittleson MM, Beavers CJ, Birnie DH, Blankstein R, Bravo PE, Gilotra NA, Judson MA, Patton KK, Rose-Bovino L, and on behalf of the American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology, and Council on Cardiovascular and Stroke Nursing:Diagnosis and Management of Cardiac Sarcoidosis:A scientific statement from the American Heart Association. Circulation 149, 2024. DOI:10.1161\/CIR.0000000000001240.","DOI":"10.1161\/CIR.0000000000001240"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Terasaki F, Azuma A, Anzai T, Ishizaka N, Ishida Y, Isobe M, Inomata T, Ishibashi-Ueda H, Eishi Y, Kitakaze M, Kusano K, Sakata Y, Shijubo N, Tsuchida A, Tsutsui H, Nakajima T, Nakatani S, Horii T, Yazaki Y, Yamaguchi E, Yamaguchi T, Ide T, Okamura H, Kato Y, Goya M, Sakakibara M, Soejima K, Nagai T, Nakamura H, Noda T, Hasegawa T, Morita H, Ohe T, Kihara Y, Saito Y, Sugiyama Y, Morimoto S, Yamashina A, and on behalf of the Japanese Circulation Society Joint Working Group:JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis \u2015 digest version \u2015. Circ J 83:2329-2388, 2019. DOI:10.1253\/circj.CJ-19-0508.","DOI":"10.1253\/circj.CJ-19-0508"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, Judson MA, Kron J, Mehta D, Cosedis Nielsen J, Patel AR, Ohe T, Raatikainen P , Soejima K:HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 11:1304-1323, 2014. DOI:10.1016\/j.hrthm.2014.03.043.","DOI":"10.1016\/j.hrthm.2014.03.043"},{"key":"12","unstructured":"12. Judson MA, Costabel U, Drent M, Wells A, Maier L, Koth L, Shigemitsu H, Culver DA, Gelfand J, Valeyre D, Sweiss N, Crouser E, Morgenthau AS, Lower EE, Azuma A, Ishihara M, Morimoto S-I, Tetsuo Yamaguchi T, Shijubo N, Grutters JC, Rosenbach M, Li H-P, Rottoli P, Inoue Y, Prasse A, Baughman RP and Organ Assessment Instrument Investigators TWS:The WASOG Sarcoidosis Organ Assessment Instrument:An update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis Off J WASOG 31:19-27, 2014. PMID:24751450."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kiuchi S, Teraoka K, Koizumi K, Takazawa K, Yamashina A:Usefulness of late gadolinium enhancement combined with MRI and 67-Ga scintigraphy in the diagnosis of cardiac sarcoidosis and disease activity evaluation. Int J Cardiovasc Imaging 23:237-241, 2007. PMID:16868855. DOI:10.1007\/s10554-006-9134-3.","DOI":"10.1007\/s10554-006-9134-3"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Futamatsu H, Suzuki J, Adachi S, Okada H, Otomo K, Ohara T, Hashimoto Y, Kakuta T, Iesaka Y, Yamaguchi H, Sakurada H, Sato A, Obayashi T, Niwa A, Hirao K, Isobe M:Utility of gallium-67 scintigraphy for evaluation of cardiac sarcoidosis with ventricular tachycardia. Int J Cardiovasc Imaging 22:443-448, 2006. PMID:16763884. DOI:10.1007\/s10554-005-9043-x.","DOI":"10.1007\/s10554-005-9043-x"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15 .Oyama-Manabe N, Manabe O, Aikawa T, Tsuneta S:The role of multimodality imaging in cardiac sarcoidosis. Korean Circ J 51:561-578, 2021. PMID:34085435. DOI:10.4070\/kcj.2021.0104.","DOI":"10.4070\/kcj.2021.0104"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Wand AL, Chrispin J, Saad E, Mukherjee M, Hays AG, Gilotra NA:Current state and future directions of multimodality imaging in cardiac sarcoidosis. Front Cardiovasc Med 8:785279, 2022. DOI:10.3389\/fcvm.2021.785279.","DOI":"10.3389\/fcvm.2021.785279"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Birnie DH, Nery PB, Ha AC, Beanlands RSB:Cardiac Sarcoidosis. J Am Coll Cardiol 68:411-421, 2016. DOI:10.1016\/j.jacc.2016.03.605.","DOI":"10.1016\/j.jacc.2016.03.605"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Al Hayja MA, Vinjamuri S:Cardiac sarcoidosis:the role of cardiac MRI and 18F-FDG-PET\/CT in the diagnosis and treatment follow-up. Br J Cardiol 30:7, 2023. PMID:37705835. DOI:10.5837\/bjc.2023.007.","DOI":"10.5837\/bjc.2023.007"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Divakaran S, Blankstein R:FDG PET imaging in suspected cardiac sarcoidosis:diagnosis vs. prognosis. J Nucl Cardiol 29:2471-2473, 2022. DOI:10.1007\/s12350-021-02809-1.","DOI":"10.1007\/s12350-021-02809-1"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Coleman GC, Shaw PW, Balfour PC, Gonzalez JA, Kramer CM, Patel AR, Salerno M:Prognostic value of myocardial scarring on CMR in patients with cardiac sarcoidosis. JACC Cardiovasc Imaging 10:411-420, 2017. DOI:10.1016\/j.jcmg.2016.05.009.","DOI":"10.1016\/j.jcmg.2016.05.009"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Campisi R, Merani MF, Rodr\u00edguez MI:Assessment of cardiac sarcoidosis:FDG PET and BMIPP SPECT. Curr Cardiol Rep 24:1873-1882, 2022. DOI:10.1007\/s11886-022-01803-4.","DOI":"10.1007\/s11886-022-01803-4"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Manabe O, Tamaki N:Potential roles of 123I-BMIPP SPECT to assess cardiac sarcoidosis. J Nucl Cardiol 28:936-938, 2021. DOI:10.1007\/s12350-021-02654-2.","DOI":"10.1007\/s12350-021-02654-2"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Bois JP, Muser D, Chareonthaitawee P:PET\/CT evaluation of cardiac sarcoidosis. PET Clin 14:223-232, 2019. DOI:10.1016\/j.cpet.2018.12.004.","DOI":"10.1016\/j.cpet.2018.12.004"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Chareonthaitawee P, Beanlands RS, Chen W, Dorbala S, Miller EJ, Murthy VL, Birnie DH, Chen ES, Cooper LT, Tung RH, White ES, Borges-Neto S, Di Carli MF, Gropler RJ, Ruddy TD, Schindler TH, Blankstein R:Joint SNMMI\u2013ASNC expert consensus document on the role of 18 F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Med 58:1341-1353, 2017. DOI:10.2967\/jnumed.117.196287.","DOI":"10.2967\/jnumed.117.196287"},{"key":"25","unstructured":"25. Norikane T, Yamamoto Y, Takami Y, Mitamura K, Kobata T, Maeda Y, Noma T, Nishiyama Y:Physiological myocardial 18F-FDG uptake pattern in oncologic PET\/CT:comparison with findings in cardiac sarcoidosis. Asia Ocean J Nucl Med Biol 12, 2024. DOI:10.22038\/aojnmb.2023.70254.1490."},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Kaneko K, Nagao M, Yamamoto A, Sakai A, Sakai S:FDG uptake patterns in isolated and systemic cardiac sarcoidosis. J Nucl Cardiol 30:1065-1074, 2023. DOI:10.1007\/s12350-022-03106-1.","DOI":"10.1007\/s12350-022-03106-1"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27. Kataoka S, Momose M, Fukushima K, Serizawa N, Suzuki A, Kondo C, Abe K, Sakai S, Hagiwara N:Regional myocardial damage and active inflammation in patients with cardiac sarcoidosis detected by non-invasive multi-modal imaging. Ann Nucl Med 31:135-143, 2017. DOI:10.1007\/s12149-016-1136-1.","DOI":"10.1007\/s12149-016-1136-1"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. Chareonthaitawee P, Bois JP:Quantitative FDG PET\/CT to Guide Treatment of Cardiac Sarcoidosis:A Crucial Step Forward. JACC Cardiovasc Imaging 14:2017-2019, 2021. PMID:33744154. DOI:10.1016\/j.jcmg.2021.01.023.","DOI":"10.1016\/j.jcmg.2021.01.023"},{"key":"29","doi-asserted-by":"publisher","unstructured":"29. Lee P-I, Cheng G, Alavi A:The role of serial FDG PET for assessing therapeutic response in patients with cardiac sarcoidosis. J Nucl Cardiol 24:19-28, 2017. DOI:10.1007\/s12350-016-0682-1.","DOI":"10.1007\/s12350-016-0682-1"},{"key":"30","doi-asserted-by":"publisher","unstructured":"30. Fukushima K, Nagao M, Yamamoto A, Serizawa N, Ishizaki U, Suzuki A, Sakai A, Watanabe E, Momose M, Kuji I, Abe K:Discrepancy between significant fibrosis and active inflammation in patients with cardiac sarcoidosis:combined and image fusion analysis of cardiac magnetic resonance and 18F fluorodeoxyglucose positron emission tomography. Eur J Hybrid Imaging 3:9, 2019. PMID:34191189. DOI:10.1186\/s41824-019-0056-4.","DOI":"10.1186\/s41824-019-0056-4"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31. Elwazir MY, Bois JP, Abou Ezzeddine OF, Chareonthaitawee P:Imaging and Quantification of Cardiac Sarcoidosis. Semin Nucl Med 50:283-294, 2020. DOI:10.1053\/j.semnuclmed.2020.03.005.","DOI":"10.1053\/j.semnuclmed.2020.03.005"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Alfawara MS, Ahmed AI, Saad JM, Han Y, Alahdab F, Al Rifai M, Kassi M, Alnabelsi T, Zoghbi WA, Al-Mallah MH:The utility of beta-hydroxybutyrate in detecting myocardial glucose uptake suppression in patients undergoing inflammatory [18F]-FDG PET studies. Eur J Nucl Med Mol Imaging 50:1103-1110, 2023. DOI:10.1007\/s00259-022-06062-7.","DOI":"10.1007\/s00259-022-06062-7"},{"key":"33","doi-asserted-by":"publisher","unstructured":"33. Madamanchi C, Weinberg RL, Murthy VL:Utility of serum ketone levels for assessment of myocardial glucose suppression for 18F-fluorodeoxyglucose PET in patients referred for evaluation of endocarditis. J Nucl Cardiol 30:928-937, 2023. DOI:10.1007\/s12350-023-03209-3.","DOI":"10.1007\/s12350-023-03209-3"},{"key":"34","doi-asserted-by":"publisher","unstructured":"34. Ning N, Guo HH, Iagaru A, Mittra E, Fowler M, Witteles R:Serial cardiac FDG-PET for the diagnosis and therapeutic guidance of patients with cardiac sarcoidosis. J Card Fail 25:307-311, 2019. DOI:10.1016\/j.cardfail.2019.02.018.","DOI":"10.1016\/j.cardfail.2019.02.018"},{"key":"35","doi-asserted-by":"publisher","unstructured":"35. Kersey CB, Flaherty KR, Goldenthal IL, Bokhari S, Biviano AB:The use of serial cardiac 18F-fluorodeoxyglucose\u2013 positron emission tomography imaging to diagnose, monitor, and tailor treatment of cardiac sarcoidosis patients with arrhythmias:a case series and review. Eur Heart J Case Rep 3:1-7, 2019. PMID:32123792. DOI:10.1093\/ehjcr\/ytz188.","DOI":"10.1093\/ehjcr\/ytz188"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Al-Suqri B, Al-Bulushi N:Gallium-67 scintigraphy in the era of positron emission tomography and computed tomography:tertiary centre experience. Sultan Qaboos Univ Med J 15:e338-343, 2015. DOI:10.18295\/squmj.2015.15.03.006.","DOI":"10.18295\/squmj.2015.15.03.006"},{"key":"37","doi-asserted-by":"publisher","unstructured":"37. Israel HL, Albertine KH, Park CH, Patrick H:Whole-body Gallium 67 scans:role in diagnosis of sarcoidosis. Am Rev Respir Dis, 2012. DOI:10.1164\/ajrccm\/144.5.1182.","DOI":"10.1164\/ajrccm\/144.5.1182"},{"key":"38","doi-asserted-by":"publisher","unstructured":"38. Travin MI:Radionuclide imaging for cardiac sarcoidosis:Much potential benefit, but still much to do. Ann Nucl Cardiol 6:53-60, 2020. PMID:37123488. DOI:10.17996\/anc.20-00115.","DOI":"10.17996\/anc.20-00115"},{"key":"39","doi-asserted-by":"publisher","unstructured":"39. Kouranos V, Sharma R:Cardiac magnetic resonance imaging as screening for cardiac sarcoidosis or not? Pol Heart J Kardiologia Pol 80:875-876, 2022. DOI:10.33963\/KP.a2022.0229.","DOI":"10.33963\/KP.a2022.0229"},{"key":"40","doi-asserted-by":"publisher","unstructured":"40. Kouranos V, Tzelepis GE, Rapti A, Mavrogeni S, Aggeli K, Douskou M, Prasad S, Koulouris N, Sfikakis P, Wells A, Gialafos E:Complementary role of CMR to conventional screening in the diagnosis and prognosis of cardiac sarcoidosis. JACC Cardiovasc Imaging 10:1437-1447, 2017. PMID:28330653. DOI:10.1016\/j.jcmg.2016.11.019.","DOI":"10.1016\/j.jcmg.2016.11.019"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Smedema J-P, Snoep G, van Kroonenburgh MPG, van Geuns R-J, Dassen WRM, Gorgels APM, Crijns HJGM:Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 45:1683-1690, 2005. PMID:15893188. DOI:10.1016\/j.jacc.2005.01.047.","DOI":"10.1016\/j.jacc.2005.01.047"},{"key":"42","doi-asserted-by":"publisher","unstructured":"42. Athwal PSS, Chhikara S, Ismail MF, Ismail K, Ogugua FM, Kazmirczak F, Bawaskar PH, Elton AC, Markowitz J, von Wald L, Roukoz H, Bhargava M, Perlman D, Shenoy C:Cardiovascular magnetic resonance imaging phenotypes and long-term outcomes in patients with suspected cardiac sarcoidosis. JAMA Cardiol 7:1057-1066, 2022. DOI:10.1001\/jamacardio.2022.2981.","DOI":"10.1001\/jamacardio.2022.2981"},{"key":"43","doi-asserted-by":"publisher","unstructured":"43. Hulten E, Agarwal V, Cahill M, Cole G, Vita T, Parrish S, Bittencourt MS, Murthy VL, Kwong R, Di Carli MF, Blankstein R:Presence of late gadolinium enhancement by cardiac magnetic resonance among patients with suspected cardiac sarcoidosis is associated with adverse cardiovascular prognosis:A systematic review and meta-analysis. Circ Cardiovasc Imaging 9, 2016. DOI:10.1161\/CIRCIMAGING.116.005001.","DOI":"10.1161\/CIRCIMAGING.116.005001"},{"key":"44","doi-asserted-by":"publisher","unstructured":"44. Patel R, Mistry AM, Mulukutla V, Prajapati K:Cardiac sarcoidosis:A literature review of current recommendations on diagnosis and management. Cureus 15:e41451, 2023. DOI:10.7759\/cureus.41451.","DOI":"10.7759\/cureus.41451"},{"key":"45","doi-asserted-by":"publisher","unstructured":"45. Stevenson A, Bray JJH, Tregidgo L, Ahmad M, Sharma A, Ng A, Siddiqui A, Khalid AA, Hylton K, Ionescu A, Providencia R, Kirresh A:Prognostic value of late gadolinium enhancement detected on cardiac magnetic resonance in cardiac sarcoidosis. JACC Cardiovasc Imaging 16:345-357, 2023. DOI:10.1016\/j.jcmg.2022.10.018.","DOI":"10.1016\/j.jcmg.2022.10.018"},{"key":"46","doi-asserted-by":"publisher","unstructured":"46. Vita T, Okada DR, Veillet-Chowdhury M, Bravo PE, Mullins E, Hulten E, Agrawal M, Madan R, Taqueti VR, Steigner M, Skali H, Kwong RY, Stewart GC, Dorbala S, Di Carli MF, Blankstein R:Complementary value of cardiac magnetic resonance imaging and positron emission tomography\/computed tomography in the assessment of cardiac sarcoidosis. Circ Cardiovasc Imaging 11:e007030, 2018. DOI:10.1161\/CIRCIMAGING.117.007030.","DOI":"10.1161\/CIRCIMAGING.117.007030"},{"key":"47","doi-asserted-by":"publisher","unstructured":"47. Cheung E, Ahmad S, Aitken M, Chan R, Iwanochko RM, Balter M, Metser U, Veit-Haibach P, Billia F, Moayedi Y, Ross HJ, Hanneman K:Combined simultaneous FDG-PET\/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis. Eur J Hybrid Imaging 5:24, 2021. DOI:10.1186\/s41824-021-00119-w.","DOI":"10.1186\/s41824-021-00119-w"},{"key":"48","doi-asserted-by":"publisher","unstructured":"48. .O\u2019Brien AT, Gil KE, Varghese J, Simonetti OP, Zareba KM:T2 mapping in myocardial disease:a comprehensive review. J Cardiovasc Magn Reson 24:33, 2022. DOI:10.1186\/s12968-022-00866-0.","DOI":"10.1186\/s12968-022-00866-0"},{"key":"49","doi-asserted-by":"publisher","unstructured":"49. Puntmann VO, Isted A, Hinojar R, Foote L, Carr-White G, Nagel E:T1 and T2 mapping in recognition of early cardiac involvement in systemic sarcoidosis. Radiology 285:63-72, 2017. DOI:10.1148\/radiol.2017162732.","DOI":"10.1148\/radiol.2017162732"},{"key":"50","doi-asserted-by":"publisher","unstructured":"50. Amano Y, Omori Y, Ando C, Yanagisawa F, Suzuki Y, Tang X, Kobayashi H, Takagi R, Matsumoto N:Clinical importance of myocardial T2 mapping and texture analysis. Magn Reson Med Sci 20:139-151, 2020. PMID:32389929. DOI:10.2463\/mrms.rev.2020-0007.","DOI":"10.2463\/mrms.rev.2020-0007"},{"key":"51","doi-asserted-by":"publisher","unstructured":"51. Greulich S, Kitterer D, Latus J, Aguor E, Steubing H, Kaesemann P, Patrascu A, Greiser A, Groeninger S, Mayr A, Braun N, Alscher MD, Sechtem U, Mahrholdt H:Comprehensive cardiovascular magnetic resonance assessment in patients with sarcoidosis and preserved left ventricular ejection fraction. Circ Cardiovasc Imaging 9:e005022, 2016. DOI:10.1161\/CIRCIMAGING.116.005022.","DOI":"10.1161\/CIRCIMAGING.116.005022"},{"key":"52","doi-asserted-by":"publisher","unstructured":"52. Suzuki M, Izawa Y, Fujita H, Miwa K, Takahashi Y, Toh H, Toba T, Fujiwara S, Hashimura H, Kono AK, Hirata K:Efficacy of myocardial washout of 99mTc-MIBI\/Tetrofosmin for the evaluation of inflammation in patients with cardiac sarcoidosis:comparison with 18F-fluorodeoxyglucose positron emission tomography findings. Ann Nucl Med 36:544-552, 2022. DOI:10.1007\/s12149-022-01735-7.","DOI":"10.1007\/s12149-022-01735-7"},{"key":"53","doi-asserted-by":"publisher","unstructured":"53. Surasi DS, Manapragada PP, Lloyd SG, Bhambhvani P:Role of multimodality imaging including Thallium-201 myocardial perfusion imaging in the diagnosis and monitoring of treatment response in cardiac sarcoidosis. J Nucl Cardiol 21:849-852, 2014. DOI:10.1007\/s12350-014-9861-0.","DOI":"10.1007\/s12350-014-9861-0"},{"key":"54","doi-asserted-by":"publisher","unstructured":"54. Ahmed AI, Abebe AT, Han Y, Alnabelsi T, Agrawal T, Kassi M, Aljizeeri A, Taylor A, Tleyjeh IM, Al-Mallah MH:The prognostic role of cardiac positron emission tomography imaging in patients with sarcoidosis:A systematic review. J Nucl Cardiol 28:1545-1552, 2021. DOI:10.1007\/s12350-021-02681-z.","DOI":"10.1007\/s12350-021-02681-z"},{"key":"55","doi-asserted-by":"publisher","unstructured":"55. Saric P, Young KA, Rodriguez-Porcel M, Chareonthaitawee P:PET imaging in cardiac sarcoidosis:A narrative review with focus on novel PET tracers. Pharmaceuticals 14:1286, 2021. PMID:34959686. DOI:10.3390\/ph14121286.","DOI":"10.3390\/ph14121286"},{"key":"56","doi-asserted-by":"publisher","unstructured":"56. Manabe O, Takahashi K, Kawakami H, Ohtsuka A, Aikawa T, Maki H, Ibe T, Fujita H, Oyama-Manabe N:Diagnostic values of delayed additional FDG PET\/CT scan in the evaluation of cardiac sarcoidosis. Ann Nucl Med 37:535-540, 2023. DOI:10.1007\/s12149-023-01855-8.","DOI":"10.1007\/s12149-023-01855-8"},{"key":"57","doi-asserted-by":"publisher","unstructured":"57. Lucinian YA, Martineau P, Poenaru R, Tremblay-Gravel M, Cadrin-Tourigny J, Harel F, Pelletier-Galarneau M:FDG-PET\/CT and rest myocardial perfusion imaging to predict high-degree atrioventricular block recovery in cardiac sarcoidosis. J Nucl Cardiol 30:2490-2500, 2023. DOI:10.1007\/s12350-023-03306-3.","DOI":"10.1007\/s12350-023-03306-3"},{"key":"58","doi-asserted-by":"publisher","unstructured":"58. Lew D, Klang E, Soffer S, Morgenthau AS:current applications of artificial intelligence in sarcoidosis. Lung 201:445-454, 2023. DOI:10.1007\/s00408-023-00641-7.","DOI":"10.1007\/s00408-023-00641-7"}],"container-title":["The Journal of Medical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jmi\/72\/3.4\/72_225\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T03:57:11Z","timestamp":1762574231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jmi\/72\/3.4\/72_225\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":58,"journal-issue":{"issue":"3.4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2152\/jmi.72.225","relation":{},"ISSN":["1343-1420","1349-6867"],"issn-type":[{"value":"1343-1420","type":"print"},{"value":"1349-6867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}